Further studies may prospectively validate our findings by the measurement of CFH and determine whether treatments aimed at replenishing haptoglobin levels or at lowering iron levels might be beneficial in ARDS patients undergoing ECMO who are often exposed to chronic and subclinical hemolysis. Here, HP is linked to hemolysis.